Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of URL pharma through its subsidiary for an undisclosed amount.

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

image

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Recommended for you

Quick Links

Market News

Markets snap two week winning streak; defensives weigh

Broader markets outperform as investors buy mid-cap and small-cap shares at attractive valuations

TCS scrip: Analysts positive despite revenue miss

Management confidence on achieving strong growth in FY16 a key reason for bullishness

VRL Logistics IPO subscribed 74 times

Issue sees more than 1.2 billion bids worth Rs 25,000 crore, on strong demand from all investor categories

Copper to remain subdued on rising production, falling demand

LME inventories on the rise since last fall of almost 200,000 tonnes last year

MFs shuffle portfolios; ITC, TCS & ONGC out of top picks

HDFC Bank pips ICICI Bank, emerges as most sought after stock

 

Back to Top